Synergistic Inhibitions of Gram‐Negative Bacteria by Combination Treatment with Ciprofloxacin and a Novel Glucolipid
Abstract Psychrophilic fungus Pseudogymnoascus sp. OUCMDZ‐4032 derived from Antarctica was cultivated under 16 °C to produce a new glucolipid compound ( 1 ). Its structure was elucidated by analysis of detailed spectroscopic data, acid hydrolysis and 1‐phenyl‐3‐methyl‐5‐pyrazolone precolumn derivati...
Published in: | Chemistry & Biodiversity |
---|---|
Main Authors: | , , , , |
Other Authors: | |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Wiley
2024
|
Subjects: | |
Online Access: | http://dx.doi.org/10.1002/cbdv.202400578 https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbdv.202400578 |
Summary: | Abstract Psychrophilic fungus Pseudogymnoascus sp. OUCMDZ‐4032 derived from Antarctica was cultivated under 16 °C to produce a new glucolipid compound ( 1 ). Its structure was elucidated by analysis of detailed spectroscopic data, acid hydrolysis and 1‐phenyl‐3‐methyl‐5‐pyrazolone precolumn derivatization, and 13 C NMR quantum chemical calculations. Though compound 1 did not show inhibitory activity against bacteria, it can reduce the minimum inhibitory concentration (MIC) of ciprofloxacin against Gram‐negative bacteria Pseudomonas aeruginosa , Escherichia coli , and Salmonella paratyphi by 1024, 256 and 256‐fold. Compound 1 showed potential as a synergistically inhibiting adjuvant in co‐administration with antibiotic to enhance antibacterial activities. |
---|